2013 Report details for project: Electronic Prescription Service (EPS) Release 2
| Project name | Electronic Prescription Service (EPS) Release 2 - there are 5 reports for this project: 2013, 2014, 2015, 2016, 2017 |
|---|---|
| Google search | Google search on project name (opens in new window) |
| Contracts | Contracts search (opens in new window) - under development |
| Organisation | DOH (D12) - see all reports for this organisation |
| Report year | 2013 (data is from September 2012) |
| Category | ICT - see all reports for this category |
| Description: | The Electronic Transmission of Prescriptions (ETP) Programme is delivering the Electronic Prescription Service (EPS) which is a national service that has its origins in a number of government policy initiatives from 1998. However, work on building this new service that will operate in all GP practices and pharmacies in England, began in December 2003. With 1.6 million paper prescriptions generated every working day in England and a predicted annual rise of 5 per cent, the EPS provides an alternative means of generating and processing the growing number of prescriptions The NHS Electronic Prescription Service (EPS) enables prescribers, such as GPs and practice nurses, to send prescriptions electronically to a dispenser (such as a community pharmacy or dispensing appliance contractor) of the patients choice. Dispensing contractors can subsequently send electronic reimbursement endorsement claims to the NHS Prescription Service. The main aims of the ETP programme are: o To enable the electronic transmission of prescription data in England between: - Prescribers (GP, nurses, supplementary) - Dispensing contractors (community pharmacy, dispensing doctors and dispensing appliance contractors) - The NHS Care Record Service - Reimbursement Agencies (e.g. the Business Services Authoritys NHS Prescription Services) o To facilitate the efficient, convenient and accurate dispensing of medication to patients. The scope of the programme covers all primary care prescribing and dispensing (excluding Schedule 2 and 3 controlled drugs) and supply of medicines, drugs, appliances and chemical reagents by authorised dispensing contractors. Secondary care prescriptions issued for dispensing in the community are also within scope o To enable the NHS Prescription Service to re-engineer their processes to increase capacity and reduce the unit cost of processing prescriptions. |
| DCA (RAG) | Amber/Green |
| DCA text: | OGC Gateway 5 Review forecast for November 2012 |
| Start date | 2003-11-28 |
| End date | 2014-03-31 |
| Schedule text | Programme is on schedule to end as per the current approved business case |
| Baseline | £8.85m |
| Forecast | £10.26m |
| Variance | 15.93% |
| Variance text: | Q1 costs related to the original EPS R2 business case. Following the MPA Gate 4 in May 2011, specific elements of the FBC were reviewed and updated. This led to a variance in the Q2 return. The main variance relates to a capital spend of £2m for Controlled Drugs functionality to be introduced into EPS, which was rolled over into the 2012/13 forecast from the 2011/12 budget. However, this was not included within 2012/13 budget. |
| Whole Life Cost | £36.38m |
| WLCost text: | WLC is Gov Spend There is no Non Gov Spend in this business case |
| Notes1: | |
| Notes2: | |
| Sourcefile | DH_2013.csv |
Home Selection Search All Reports Projects +dates Projects +costs Organisations Years Categories
Acknowledgement: GMPP data has been re-used under the Open Government Licence.